The group’s principle activity is to foster the commercial development of small molecule drug discovery and development in pharmaceutical, discovery platform, and biotechnology companies. The group also provides custom organic synthesis using diverse chemistries to produce active pharmaceutical ingredients and scaffolds. The group operates from United States.
